Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma | Blood | 2009 | 597 |
Increasing burden of melanoma in the United States | Journal of Investigative Dermatology | 2009 | 505 |
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project | Lancet Oncology, The | 2009 | 385 |
A phase I study with neratinib (HKI-272), an irreversible pan ErbB receptor tyrosine kinase inhibitor, in patients with solid tumors | Clinical Cancer Research | 2009 | 230 |
Acquired copy number alterations in adult acute myeloid leukemia genomes | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 209 |
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer | Breast Cancer Research and Treatment | 2009 | 159 |
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib | Pediatric Blood and Cancer | 2009 | 124 |
Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans | Magnetic Resonance in Medicine | 2009 | 97 |
The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 89 |
Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? | Cancer Epidemiology Biomarkers and Prevention | 2009 | 87 |
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 | Blood | 2009 | 87 |
MLL fusions: pathways to leukemia | Cancer Biology and Therapy | 2009 | 78 |
Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13 | Blood | 2009 | 64 |
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer | Clinical Cancer Research | 2009 | 61 |
Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy | Journal of Vascular and Interventional Radiology | 2009 | 54 |
Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesis | PLoS ONE | 2009 | 43 |
Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases | World Neurosurgery | 2009 | 41 |
Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases | Clinical Cancer Research | 2009 | 39 |
The effect of mesh reinforcement of a stapled transection line on the rate of pancreatic occlusion failure after distal pancreatectomy: review of a single institution's experience | Hpb | 2009 | 35 |
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial | Breast Cancer Research and Treatment | 2009 | 30 |
Differential expression of granzyme B and C in murine cytotoxic lymphocytes | Journal of Immunology | 2009 | 27 |
Cancer stem cells: a guide for skeptics | Journal of Cellular Biochemistry | 2009 | 27 |
Weight Management Among Patients at Community Health Centers: The “Be Fit, Be Well” Study | Obesity and Weight Management | 2009 | 26 |
Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma | Experimental Hematology | 2009 | 26 |
Dicer and outcomes in patients with acute myeloid leukemia (AML) | Leukemia Research | 2009 | 26 |